Marisa Freitas

TL;DR: The burden of CKD was much higher than expected for the level of development, whereas the disease burden in western, eastern, and central sub-Saharan Africa, east Asia, south Asia, central and eastern Europe, Australasia, and western Europe was lower than expected.

TL;DR: The Global Burden of Disease (GBD) study as discussed by the authors has been used to describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning, including cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs).

TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 produced updated and comprehensive demographic assessments of the key indicators of fertility, mortality, migration, and population for 204 countries and territories and selected subnational locations from 1950 to 2019.

TL;DR: Five key insights that are important for health, social, and economic development strategies have been distilled are distilled and are subject to the many limitations outlined in each of the component GBD capstone papers.

TL;DR: The present work suggests that several of the studied flavonoids have the potential to be used as alternatives for the regulation of PPHG, with a flavonoid with two catechol groups in A- and B-rings being the most active.